Healthcare Marketing Blogs

02|20|25

Building Trust With Education and Innovation: Rare Disease Marketing

Rare and ultra-rare diseases face problems most brands do … turned up to 11. Budgets? Smaller. Patient pool? Even smaller. Healthcare providers (HCPs) who understand the condition? Sometimes even smaller than that. Treatment options can be limited, access can be hard to find and diagnosis time can sometimes be measured in decades rather than months. […]

02|06|25

Pharma Marketing and the Super Bowl: A Missed Opportunity?

During the Super Bowl, is when we see some of the most entertaining and memorable commercials. However, pharmaceutical companies often remain on the sidelines during this prime advertising opportunity. In a recent article in MM+M, pharma industry thought leaders, including John Kenny, Chief Strategy Officer, and Susan Perlbachs, Chief Creative Officer, offer their insights as to why pharma brands are hesitant to invest in Super Bowl ads despite the massive audience.

01|28|25

Pharma Marketing in 2025: Talking Trends With Angela Tenuta

In a rapidly evolving industry, staying ahead of the curve is critical. In PM360's article, “What Is Pharma Marketing in 2025?” Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Read the blog to learn more.

01|24|25

Creating Award-Winning Work: Insights From Susan Perlbachs With Muse by Clios

In a recent interview with Muse by Clios, Susan Perlbachs, Chief Creative Officer, offered profound insights into the ever-changing world of healthcare advertising. Dive into our blog to discover the secrets behind creating award-winning campaigns and explore inspiring examples.

12|13|24

Global Health Equity: Moving From Wish List to To-Do List

This excerpt is from a recent interview with Angela Tenuta, President of EVERSANA INTOUCH, featured in PharmaLive where she emphasizes the importance of addressing disparities in healthcare access and outcomes across different populations. It highlights actionable steps and innovative approaches that can be taken to ensure equitable healthcare for all.

12|03|24

The Balancing Act: Sourcing & Pricing Meet Innovation in Life Sciences

EVERSANA INTOUCH recently hosted an insightful panel at the 2024 ProcureCon Marketing conference in Los Angeles. The panel, titled "The Balancing Act: Sourcing & Pricing Meet Innovation in Life Sciences," brought together industry leaders to discuss the intersection of cost efficiency and innovation in the dynamic field of life sciences. Read the blog to learn more.

11|26|24

Ethical Considerations for AI Use in Healthcare Marketing

The healthcare marketing industry is at the forefront of a significant transformation, driven by advances in artificial intelligence (AI). Today, generative AI applications – particularly large language models (LLMs) and image-generation tools – are streamlining labor-intensive tasks such as research, documentation, content editing and concept ideation. These developments mark only the beginning of what AI can achieve in healthcare marketing. 

11|18|24

What Matters Most: The Three Trends That Will Change Pharma Marketing in 2025

This year’s EVERSANA INTOUCH annual trends forecast – our ninth! – is both smaller and bigger than those that have come before it. Technology (No. 1: applied AI) is enabling entirely new ways to do business (No. 2: the direct-to-patient model) in a paradigm that’s interconnected (No. 3: globalization and health equity) at every level. […]

10|24|24

Can a Celebrity Influencer Work for Your Brand?

In a recent article for PM360, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, delves into the growing trend of celebrity influencers in pharmaceutical advertising, exploring both the opportunities and challenges they present. She highlights how celebrities can provide brands with instant recognition and broad reach, sharing examples like Travis Kelce’s involvement in Pfizer’s “Got […]

09|27|24

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Every year, ESMO brings together experts from pharma, research and advocacy organizations, and HCPs to hear about the year’s biggest oncology breakthroughs. This year’s theme was “Shaping the Future of Anticancer Therapies.”